E
Eupraxia Pharmaceuticals Inc. (EPRX)
NCM – Real Time Price. Currency in USD
7.61
+0.19 (2.56%)
At close: May 12, 2026, 4:00 PM EDT
8.40
+0.79 (10.38%)
After-hours: May 12, 2026, 7:43 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
7.61
+0.19 (2.56%)
At close: May 12, 2026, 4:00 PM EDT
8.40
+0.79 (10.38%)
After-hours: May 12, 2026, 7:43 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $80.4M significantly exceed its total debt $154.1K, ensuring strong financial flexibility
Total current assets $84.9M exceed Total current liabilities $5.6M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$10.1M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 15.12 | 6.05 | 10 | |
| Quick ratio | 15.12 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -143K | -158K | -163K | -242K | -239K |
| Operating Income | -17M | -29M | -26M | -39M | -39M |
| Net Income | -17M | -29M | -24M | -39M | -39M |
| EBITDA | -17M | -28M | -26M | -39M | -38M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -3.65 | 1.0 |
| Next quarter | N/A | 28.06 | 5.5 |
| Current year | N/A | 8.96 | 3.5 |
| Next year | N/A | 11.43 | 4.0 |
| Weighted average score | 3.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -169.75 | -59 | -125.68 | 3.3 |
| Y/Y | 999 | -132.52 | -45.95 | -70.4 | 3.3 |
| 3y average | 999 | -37.86 | 1.49 | -29.71 | 3.8 |
| 5y average | 999 | -117.45 | -28.94 | -753.17 | 3.3 |
| Weighted average score | 3.4 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |